Abstract:Infants are highly susceptible to invasive respiratory and gastrointestinal infections. To elucidate the age-dependent mechanism(s) that drive bacterial spread from the mucosa, we developed an infant mouse model using the prevalent pediatric respiratory pathogen, Streptococcus pneumoniae ( Spn ). Despite similar upper respiratory tract (URT) colonization levels, the survival rate of Spn -infected infant mice was significantly decreased compared to adults and corresponded with Spn dissemination to the bloodstream. An increased rate of pneumococcal bacteremia in early life beyond the newborn period was attributed to increased bacterial translocation across the URT barrier. Bacterial dissemination in infant mice was independent of URT monocyte or neutrophil infiltration, phagocyte-derived ROS or RNS, inflammation mediated by toll-like receptor 2 or interleukin 1 receptor signaling, or the pore-forming toxin pneumolysin. Using molecular barcoding of Spn , we found that only a minority of bacterial clones in the nasopharynx disseminated to the blood in infant mice, indicating the absence of robust URT barrier breakdown. Rather, transcriptional profiling of the URT epithelium revealed a failure of infant mice to upregulate genes involved in the tight junction pathway. Expression of many such genes was also decreased in early life in humans. Infant mice also showed increased URT barrier permeability and delayed mucociliary clearance during the first two weeks of life, which corresponded with tighter attachment of bacteria to the respiratory epithelium. Together, these results demonstrate a window of vulnerability during postnatal development when altered mucosal barrier function facilitates bacterial dissemination. In children, bacterial respiratory and gastrointestinal pathogens remain major contributors to childhood mortality worldwide. Yet, the immune deficiencies intrinsic to early age that compromise bacterial control during infection remain relatively unknown. In this study, we utilized clinically relevant infant mouse models and a human newborn study to characterize mucosal barrier defenses that are critical for mediating resistance to invasive infection. Using the prominent pediatric respiratory pathogen, Streptococcus pneumoniae ( Spn ), we show that the postnatal period is associated with an increased susceptibility to invasive Spn infection following nasal colonization. In contrast to adult mice, infant mice exhibited increased bacterial translocation across the nasal mucosal barrier that was independent of robust barrier damage. Instead, transcriptional analysis of the nasal epithelium in infant mice revealed decreased expression of tight junction proteins that corresponded with increased barrier permeability and delayed mucociliary clearance. Strikingly, a similar transcriptional signature was also observed in nasopharyngeal samples collected from human infants during the first year of life. These findings suggested that disruption in barrier integrity and function may be a hallmark of postnatal development. Collectively, our data underscores a vulnerable period during early life when impaired nasal barrier defenses facilitate bacterial translocation, culminating in invasive infection.

Suppression of IL-17 producing type 3 innate lymphoid cells and increased susceptibility to Klebsiella pneumoniae sepsis in neonatal mice exposed to extended empiric antibiotics

Prevalence of Multidrug-Resistant Pathogens Causing Neonatal Early and Late Onset Sepsis, a Retrospective Study from the Tertiary Referral Children’s Hospital

Antibiotic Exposure Prevents Acquisition of Beneficial Metabolic Functions in the Preterm Infant Gut Microbiome

The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice

The balance between protective and pathogenic immune responses to pneumonia in the neonatal lung is enforced by gut microbiota

Disruption of maternal IgA by prenatal antibiotics precedes intestinal colonization and late-onset sepsis in neonates

Decreased production of epithelial-derived antimicrobial molecules at mucosal barriers during early life

Impaired upper respiratory tract barrier function during postnatal development predisposes to invasive pneumococcal disease

The gut microbiome, resistome, and mycobiome in preterm newborn infants and mouse pups: lack of lasting effects by antimicrobial therapy or probiotic prophylaxis

The Epidemiology of Invasive, Multipleantibiotic-resistant Klebsiella pneumoniae Infection in a Breeding Colony of Immunocompromised NSG Mice

An Antibiotic-Impacted Microbiota Compromises the Development of Colonic Regulatory T Cells and Predisposes to Dysregulated Immune Responses

Antepartum Antibiotic Treatment Increases Offspring Susceptibility to Experimental Colitis: A Role of the Gut Microbiota

Peripartum Antibiotics Promote Gut Dysbiosis, Loss of Immune Tolerance, and Inflammatory Bowel Disease in Genetically Prone Offspring

Loading ceftriaxone, vancomycin, and Bifidobacteria bifidum TMC3115 to neonatal mice could differently and consequently affect intestinal microbiota and immunity in adulthood

Attenuated innate immune defenses in very premature neonates during the neonatal period

Effect of β-lactam antibiotics on the gut microbiota of term neonates

Impact of early antibiotic exposure on the risk of colonization with potential pathogens in very preterm infants: a retrospective cohort analysis

Maternal antibiotic exposure enhances ILC2 activation in neonates via downregulation of IFN1 signaling

Neonatal antibiotic treatment alters gastrointestinal tract developmental gene expression and intestinal barrier transcriptome

Early and Late Onset Neonatal Sepsis: Epidemiology and Effectiveness of Empirical Antibacterial Therapy in a III Level Neonatal Intensive Care Unit

Impact of total parenteral nutrition and antibiotics on hepatic and intestinal homeostasis in pediatric murine model